STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a new drug called sEphB4-HSA combined with standard chemotherapy in 61 people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The goal was to find the best dose and check for side effects. Whi…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Gene-Edited cell therapy for lung cancer trial pulled before start
Disease control TerminatedThis trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. It used a patient's own immune cells (TILs) that were edited with CRISPR to remove a gene called CISH, potentially making them better at fighting cancer. The study was withdrawn before…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug combo aims to shrink Hard-to-Treat lung tumors
Disease control OngoingThis early-phase study tests a combination of two drugs, ceritinib and docetaxel, in people with advanced non-small cell lung cancer that does not have certain gene changes (ALK-negative, EGFR wild-type). The main goal is to find the safest dose and see if the combination can shr…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New hope for advanced lung cancer: adding targeted treatment may extend life
Disease control OngoingThis study tests whether adding local treatments like radiation or surgery to standard maintenance chemotherapy helps people with stage IV non-small cell lung cancer live longer without the disease getting worse. About 218 participants are randomly assigned to receive either chem…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Blood test could predict which cancer treatments work best
Knowledge-focused OngoingThis study aims to develop a blood test that can predict whether a cancer treatment will be effective for a patient. Researchers are collecting blood samples from 10,000 people with advanced lung cancer or melanoma before and during therapy. By analyzing proteins in the blood, th…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC